Epoch (Accelerator)

Company Description: It's our vision to build a healthy, equitable and sustainable world, and we believe we can do this by making biology fundamental to every industry on earth.Based off of 20 years of research by Professor Douglas Kell, CBE, we're building a computational platform for intelligent enzyme development. We take advantage of advanced AI and Deep Learning, combined with proprietary lab automation and genomic sequencing to intelligently navigate the vast search space of enzymes. This allows us to design and discover enzymes for any purpose, and in timelines to suit client need.We have first applied this to solve the plastics crisis, and have developed a plastic-eating enzyme that enables the bulk breakdown of mixed waste plastics. This technology will enable the direct conversion of plastics into chemicals for use in polymer manufacturing, chemicals production and other industrial processes.This technology also enables plastics to be utilised as a feedstock for bioprocesses, greatly improving the cost-competetiveness of biomaterials and specialty chemicals. Plastics are our first target, and we have plans to, and have already begun to tackle many other focus areas in health, the environment and industrial processes.